Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Workspace Group PLC Share Issue/Capital Change 2020

Jun 24, 2020

5282_dlst_2020-06-24_c6e7a0e6-ece7-48fd-983d-28e6b18f5aa6.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 9222Q

Workspace Group PLC

24 June 2020

24 June 2020

Workspace Group PLC (the "Company" or "Workspace Group")

Blocklisting Application

Application has been made for the admission of 2,036,967 ordinary shares of 100p each in the Company (the 'Shares') to the Official List of the UK Listing Authority and to trading on the London Stock Exchange. These shares are being reserved under a block listing and may be issued pursuant to the exercise before maturity of options granted under the below employee share schemes:

SCHEME NAME SHARES
WORKSPACE GROUP PLC 2017 LTIP 369,250
WORKSPACE GROUP PLC 2018 LTIP 365,085
WORKSPACE GROUP PLC 2019 LTIP 440,136
WORKSPACE GROUP PLC 2020 LTIP 650,475
WORKSPACE GROUP PLC 2015 SAYE 5 YEAR SCHEME 247
WORKSPACE GROUP PLC 2016 SAYE 5 YEAR SCHEME 347
WORKSPACE GROUP PLC 2017 SAYE 3 YEAR SCHEME 67,239
WORKSPACE GROUP PLC 2017 SAYE 5 YEAR SCHEME 762
WORKSPACE GROUP PLC 2018 SAYE 3 YEAR SCHEME 23,583
WORKSPACE GROUP PLC 2018 SAYE 5 YEAR SCHEME 174
WORKSPACE GROUP PLC 2019 SAYE 3 YEAR SCHEME 113,774
WORKSPACE GROUP PLC 2019 SAYE 5 YEAR SCHEME 5,895

The shares will be issued fully paid and will, upon issue, rank pari passu in all respects with the Company's existing issued shares. It is expected that admission will be effective for the Shares on 30 June 2020.

Enquiries:

Workspace Group PLC

Carmelina Carfora, Company Secretary

Tel: +44 (0) 20 7138 3300

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ALSUSUBRRNUNURR